Innogen Pharmaceuticals Receives PIC/S GMP Certificatation, Accelerating Global Expansion of Efsubaglutide Alfa

RegulatoryapprovedEfsubaglutide alfaPositive

AI Analysis

Summary

Innogen Pharmaceuticals announced that its Suzhou manufacturing facility for Efsubaglutide alfa has received PIC/S GMP Certification, supporting the company's global expansion efforts for this metabolic disease treatment.

Outcome Details

PIC/S GMP Certification received for manufacturing facility in Suzhou

Importance:6/10

Sentiment:

0.65

manufacturingGMP certificationglobal expansionregulatory approvalmetabolic diseases

Related Companies

$2591

Read the original article

Published by PR Newswire Biotech on August 4, 2026 5:25 AM

Read Original